ESSA Pharma to Present at the Jefferies Global Healthcare Conference
ESSA Pharma to Present at the Jefferies Global Healthcare Conference
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on Twitter and LinkedIn.SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, May 30, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 p.m. ET in New York.
ESSA医药公司（"ESSA"或"公司")（纳斯达克:EPIX）是一家临床阶段的药物公司，专注于开发治疗前列腺癌的新型疗法。今天宣布，该公司将在2024年6月6日星期四上午12:30在纽约的杰弗里斯全球医疗保健会议上发表演讲。
David. R. Parkinson, President, and Chief Executive Officer and David S. Wood, Chief Financial Officer, will host and participate in one-on-one meetings.
David. R. Parkinson（总裁兼首席执行官）和David S. Wood（首席财务官）将主持并参加一对一会议。
A live webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at . Following the event, the webcast will be archived on the ESSA website for 90 days.
演示的现场网络广播可以在ESSA的投资者/事件与演示部分网站上访问。活动结束后，网络广播将在ESSA网站上保存90天。
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit , and follow us on Twitter and LinkedIn.
ESSA是一家临床阶段的制药公司，专注于开发新型专有疗法，治疗前列腺癌患者。更多信息，请访问，并在我们之后的推特上关注我们。推特和页面。LinkedIn.
ESSA Pharma, Inc.
Peter Virsik, Chief Operating Officer
778.331.0962
[email protected]
ESSA药品公司，Inc.
彼得·维尔希克（Peter Virsik），首席运营官
778.331.0962
[email protected]
Investors and Media:
Argot Partners
212.600.1902
essa@argotpartners.com
投资者和媒体:
阿哥特合伙人。
212.600.1902
essa@argotpartners.com
SOURCE ESSA Pharma Inc
来源：ESSA Pharma Inc